Company Filing History:
Years Active: 2009
Title: Neil McIntyre: Innovator in Pharmaceutical Compounds
Introduction
Neil McIntyre is a notable inventor based in Angus, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit protein kinases. His work is crucial for advancing treatments for various medical conditions.
Latest Patents
Neil McIntyre holds a patent for "Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases." This patent describes a compound of formula 1, which includes various chemical structures and groups that can be utilized in pharmaceutical compositions. These compounds are aimed at treating proliferative disorders, viral disorders, CNS disorders, diabetes, stroke, and cardiovascular disorders.
Career Highlights
Neil McIntyre is associated with Cyclacel Limited, a company focused on developing innovative cancer therapies. His work at Cyclacel has positioned him as a key player in the pharmaceutical industry, contributing to the advancement of therapeutic solutions.
Collaborations
Neil has collaborated with notable colleagues, including Campbell McInnes and Mark Thomas. These partnerships have enhanced the research and development efforts within his field.
Conclusion
Neil McIntyre's innovative work in pharmaceutical compounds demonstrates his commitment to improving healthcare through scientific advancements. His contributions are vital for the ongoing development of effective treatments for various diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.